LatestMLB Proposes Shorter Season and Extended Playoffs Starting in 2029
Cannabis

Ohio Cannabis Retailers Face New Product Restrictions on High-Potency Items

Margaret Jackson
MJBizDaily
Summary

Ohio's Department of Commerce implemented new potency and packaging regulations for cannabis products effective Tuesday, prohibiting the sale of high-potency vaporizers and establishing limits on flower, edibles, and concentrates. These regulatory changes took effect without requiring legislative approval, representing a significant shift in the state's cannabis retail landscape. The restrictions aim to address public health concerns regarding excessive cannabinoid concentrations in consumer products. Patients and consumers in Ohio must now navigate modified product availability when seeking cannabis for therapeutic or recreational purposes. This development reflects broader national trends toward implementing potency caps on certain cannabis delivery methods.

MJ Biz Daily

Originally published on

MJBizDaily

By Margaret Jackson

Read full article(opens in new tab)

Fetched: October 9, 2026 at 10:01 AM

More news you might be interested in

View all
Australia Registers Inhaler Device for Medical Cannabis Liquid Extracts
Cannabis

Australia Registers Inhaler Device for Medical Cannabis Liquid Extracts

Australia's Therapeutic Goods Administration has registered the QMID, an inhaler device for medical cannabis liquid extracts, following an announcement by Curaleaf. The device functions with compatible cartridges and expands the range of approved delivery options for patients in Australia's medical cannabis program. This registration represents progress in standardizing cannabis administration methods, though device approval does not automatically authorize all medications for use with the inhaler. The development reflects growing regulatory recognition of inhalation as a viable delivery route for cannabinoid therapeutics, potentially offering patients more precise dosing and faster onset compared to other administration methods.

2 hours ago
Revista Cáñamo
How Art Reflects Mexico's Marijuana Legalization: A Cultural Perspective
Cannabis

How Art Reflects Mexico's Marijuana Legalization: A Cultural Perspective

An international art exhibition celebrating former Uruguayan President Pepe Mujica's legacy explores the intersection of cannabis culture and democratic regulation through contemporary artwork. The showcase examines how legalization policies reshape cultural narratives and public discourse surrounding marijuana. This exhibition provides insight into how artistic expression engages with evolving cannabis policy frameworks and societal attitudes toward regulation. The collection demonstrates art's role in facilitating important conversations about drug policy, personal freedoms, and responsible governance in Latin America.

6 hours ago
Soft Secrets (Español)
Cannabis

Germany Expands Medical Cannabis Production Capacity at Leuna Facility

Aurora Cannabis has completed the expansion of its Leuna facility in Germany, one of only a few authorized centers in the country for cultivating medical cannabis. This expansion increases Germany's domestic production capacity for pharmaceutical-grade cannabis, supporting the country's medical cannabis program that began in 2017. The Leuna facility represents a significant investment in standardized, regulated cannabis cultivation for patients requiring medical cannabis treatments. This development strengthens Germany's position as a leader in European medical cannabis production and helps ensure reliable supply for patients with approved therapeutic indications.

8 hours ago
Cannabis Magazine
MJBizDaily
Cannabis

Washington State Updates Cannabis Rules to Align with Federal Rescheduling

Washington state cannabis regulators have approved modifications to state rules enabling operators to better comply with recent federal marijuana rescheduling. This regulatory adjustment streamlines compliance procedures for licensed cannabis businesses operating under both state and federal frameworks. The rule tweaks reflect the evolving federal landscape following the rescheduling decision, which has significant implications for medical cannabis patients and industry stakeholders. These changes facilitate clearer operational guidelines while maintaining state-level oversight of the cannabis market. The updated regulations demonstrate how states are adapting their policies to align with changing federal cannabis policy.

15 hours ago
MJBizDaily